This year, Community Scientists Angela Howard, Stanley Richardson, Ty Davis, and Kristie Hill served as judges for poster presentations, offering valuable feedback grounded in lived experience and community perspectives.
A UF College of Medicine research team launched a six-month pilot award study in February that applies AI to brain tumor research. The team will investigate MRI imaging to improve predictions of how the immune systems of brain tumor patients respond to therapies. The grant from UF Health’s…
At-home kits that allow women to collect their own samples for HPV testing have been shown to improve cervical cancer screening rates. But some women lack confidence in their ability to complete the collection themselves.
We celebrate our extensive partnerships with the UF Health Cancer Institute. Several of the Institute's top stories feature our researchers and staff members.
Ramzi Salloum, Ph.D., associate director for community outreach and engagement at the UF Health Cancer Institute, has been elected vice chair of the Florida Cancer Control and Research Advisory Council.
Naomi Parker, Ph.D., an assistant scientist in the University of Florida’s Department of Health Outcomes and Biomedical Informatics, never expected her path from rural Southeast Georgia to lead to cancer communication research.
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
Working with oncologists, Carma Bylund, Ph.D., and study first author Naomi Parker, Ph.D., both from the UF Department of Health Outcomes and Biomedical Informatics, are piloting an “information prescription” to steer patients to sources of evidence-based information like the American Cancer Society.
Department of Health Outcomes and Biomedical Informatics (HOBI) faculty members will be sharing their research at the UF Health Cancer Center's Cancer AI Symposium on Nov. 5, 2025.
A new study by University of Florida researchers and collaborators has found that a popular class of weight loss drugs is associated with lower cancer risk.
